Details of the Drug Formulaction | DrugMAP

General Information of Drug Formulation (ID: F23277)

Formulation Name

Ripretinib 50 mg tablet

Company

Deciphera Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Ripretinib	DM958QB	Gastrointestinal stromal tumour	2B5B	Approved
--------------------

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Cellulose microcrystalline	E00698	Not Available	Adsorbent; Suspending agent; Diluent
Crospovidone	E00626	Not Available	Disintegrant
Hypromellose acetate succinate	E00696	Not Available	Coating agent; Solubilizing agent; Modified-release agent;Film/membrane-forming agent
Lactose monohydrate	E00393	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	E00208	11177	lubricant
Silicon dioxide	E00670	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent

--------------------